156 related articles for article (PubMed ID: 3562444)
1. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
[TBL] [Abstract][Full Text] [Related]
4. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. III. Changes in DNA synthesis and mitotic activity.
Elsässer HP; Puplat D; Adler G; Kern HF
Cell Tissue Res; 1990 Oct; 262(1):143-8. PubMed ID: 2257606
[TBL] [Abstract][Full Text] [Related]
6. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. II. Regulation of total protein and individual enzyme biosynthesis.
Rausch U; Weidenbach H; Adler G; Kern HF
Cell Tissue Res; 1987 Jul; 249(1):63-7. PubMed ID: 2441868
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
11. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
12. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
Miyasaka K; Nakamura R; Kitani K
J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
[TBL] [Abstract][Full Text] [Related]
13. Effect of atropine on feedback regulation of pancreatic secretion in rats.
Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G
Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503
[TBL] [Abstract][Full Text] [Related]
14. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
Otsuki M; Ohki A; Okabayashi Y; Suehiro I; Baba S
Pancreas; 1987; 2(2):164-9. PubMed ID: 3628222
[TBL] [Abstract][Full Text] [Related]
15. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.
Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W
Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. I. Dose-response study on enzyme content and secretion, cholecystokinin release and pancreatic fine structure.
Rausch U; Adler G; Weidenbach H; Weidenbach F; Rudolff D; Koop I; Kern HF
Cell Tissue Res; 1987 Jan; 247(1):187-93. PubMed ID: 2435411
[TBL] [Abstract][Full Text] [Related]
17. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
18. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
Göke B; Leferink J; Göke R; Adler G
Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
[TBL] [Abstract][Full Text] [Related]
19. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of single and repeated administrations of a protease inhibitor (Camostate) on pancreatic secretion in man.
Adler G; Müllenhoff A; Bozkurt T; Göke B; Koop I; Arnold R
Scand J Gastroenterol; 1988 Mar; 23(2):158-62. PubMed ID: 3363288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
